Search
for
Sort by
Research 61–90 of 540
- JAK inhibitors and alopecia areata
- The beneficial effects of Pumpkin (<i>Cucurbita pepo</i>L.) seed oil for health condition of men
- Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
- Dermoscopy of an osteonevus of Nanta
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Assessment of ameliorative potential of Aegle marmelos fruit extract against hematological and biochemical alterations in sub-acute arsenic toxicity in mice
- Clinical report of a Holstein's calf with ichthyosis.
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Patent Reports
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- COVID-19 and Sex Differences
- The pharmacology of methotrexate
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- A review of diagnosis and treatment of acne in adult female patients
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS)
- Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Alopecia Areata Update
- Safety of testosterone treatment in postmenopausal women
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Polycystic Ovary Syndrome: Diagnosis and Treatment
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Graft-versus-host disease